Symbols / BFRG
BFRG Chart
About
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 6.21M |
| Enterprise Value | 3.85M | Income | -6.76M | Sales | 116.67K |
| Book/sh | 0.19 | Cash/sh | 0.17 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 53.25 | P/B | 2.91 | P/C | — |
| EV/EBITDA | -0.56 | EV/Sales | 32.96 | Quick Ratio | 2.70 |
| Current Ratio | 3.34 | Debt/Eq | 2.86 | LT Debt/Eq | — |
| EPS (ttm) | -0.69 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-06 16:00 | ROA | -117.47% |
| ROE | -233.50% | ROIC | — | Gross Margin | 18.76% |
| Oper. Margin | -18.82% | Profit Margin | 0.00% | Shs Outstand | 11.40M |
| Shs Float | 8.97M | Short Float | 6.05% | Short Ratio | 0.38 |
| Short Interest | — | 52W High | 2.93 | 52W Low | 0.42 |
| Beta | 0.70 | Avg Volume | 647.85K | Volume | 123.70K |
| Target Price | — | Recom | None | Prev Close | $0.51 |
| Price | $0.55 | Change | 7.58% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.55
Latest analyst target
3. DCF / Fair value
$-5.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.55
Low
—
High
—
Mean
—
- $200B drug R&D meets AI: BullFrog tool targets trial failures - Stock Titan Wed, 04 Feb 2026 08
- BullFrog AI Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView ue, 17 Feb 2026 21
- Is Bullfrog AI Stock Built to Withstand More Downside? - Trefis Sat, 29 Nov 2025 08
- ZCMD, ABCL, VOR, IXHL, OVID, BFRG Rally After Hours On Clinical Momentum And Recent Updates - Nasdaq hu, 02 Oct 2025 07
- BullFrog AI Faces Nasdaq Noncompliance, Delisting Risk Looms - TipRanks ue, 17 Feb 2026 23
- BullFrog AI Holdings stockholders approve share issuance and reverse split - Investing.com Fri, 24 Oct 2025 07
- AI study spots pancreatic cancer patients living nearly 3x longer - Stock Titan ue, 06 Jan 2026 08
- Aug Big Picture: Whats the RSI of EVCM stock - July 2025 News Drivers & Technical Pattern Based Buy Signals - baoquankhu1.vn ue, 24 Feb 2026 18
- ZCMD, ABCL, VOR, IXHL, OVID, BFRG Surge in After-Hours Trading Due to Clinical Progress and Recent Developments - Intellectia AI Mon, 16 Feb 2026 01
- BullFrog AI and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Naples Daily News Fri, 24 Oct 2025 07
- Bullfrog AI Announces Closing of $8.4 Million Initial Public Offering - ACCESS Newswire Fri, 25 Apr 2025 15
- symbol__ Stock Quote Price and Forecast - CNN Wed, 17 Jan 2024 13
- Bullfrog AI Holdings Inc. (BFRG) reports earnings - qz.com Fri, 14 Mar 2025 07
- BFRG Stock Price, News & Analysis | BULLFROG AI HLDGS - Stock Titan Fri, 25 Apr 2025 01
- CEO and 10% Owner Vininder Singh Sells 50,000 Shares of Bullfrog AI Holdings Inc (BFRG) - Yahoo Finance Wed, 03 Apr 2024 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8523 | — | — | Stock Award(Grant) at price 0.00 per share. | HANSON JASON DAVID | Director | — | 2025-08-22 00:00:00 | D |
| 1 | 8523 | — | — | Stock Award(Grant) at price 0.00 per share. | ENRIGHT WILLIAM | Director | — | 2025-08-22 00:00:00 | D |
| 2 | 8523 | — | — | Stock Award(Grant) at price 0.00 per share. | ELSEY RAYMOND DONALD | Director | — | 2025-08-22 00:00:00 | D |
| 3 | 15000 | — | — | Stock Award(Grant) at price 0.00 per share. | BLACHER JOSHUA | Chief Financial Officer | — | 2025-08-22 00:00:00 | D |
| 4 | 75000 | — | — | Stock Award(Grant) at price 0.00 per share. | SINGH VININDER | Chief Executive Officer | — | 2025-08-22 00:00:00 | D |
| 5 | 29002 | 43625 | — | Sale at price 1.50 per share. | SINGH VININDER | Chief Executive Officer | — | 2025-07-07 00:00:00 | D |
| 6 | 20998 | 32911 | — | Sale at price 1.53 - 1.61 per share. | SINGH VININDER | Chief Executive Officer | — | 2025-07-03 00:00:00 | D |
| 7 | 5895 | 7686 | — | Sale at price 1.30 per share. | SINGH VININDER | Chief Executive Officer | — | 2025-04-04 00:00:00 | D |
| 8 | 44105 | 66408 | — | Sale at price 1.44 - 1.64 per share. | SINGH VININDER | Chief Executive Officer | — | 2025-04-03 00:00:00 | D |
| 9 | 5695 | 14727 | — | Sale at price 2.59 per share. | SINGH VININDER | Chief Executive Officer | — | 2024-10-09 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -6.97M | -5.28M | -2.45M | -545.45K |
| TotalUnusualItems | -92.96K | 0.00 | 9.92K | |
| TotalUnusualItemsExcludingGoodwill | -92.96K | 0.00 | 9.92K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -6.99M | -5.36M | -2.80M | -585.84K |
| ReconciledDepreciation | 1.72K | 1.73K | 1.04K | 0.00 |
| ReconciledCostOfRevenue | 0.00 | 5.20K | 800.00 | 0.00 |
| EBITDA | -6.97M | -5.28M | -2.45M | -545.45K |
| EBIT | -6.98M | -5.28M | -2.46M | -545.45K |
| NetInterestIncome | 242.74K | 104.61K | -346.69K | -40.40K |
| InterestExpense | 18.16K | 79.09K | 347.14K | 40.40K |
| InterestIncome | 260.89K | 183.70K | 459.00 | |
| NormalizedIncome | -6.99M | -5.36M | -2.80M | -585.84K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.99M | -5.36M | -2.80M | -585.84K |
| TotalExpenses | 7.24M | 5.43M | 2.47M | 555.36K |
| TotalOperatingIncomeAsReported | -7.24M | -5.37M | -2.46M | -555.36K |
| DilutedAverageShares | 8.25M | 6.05M | 5.67M | 5.65M |
| BasicAverageShares | 8.25M | 6.05M | 5.67M | 5.65M |
| DilutedEPS | -0.85 | -0.89 | -0.49 | -0.10 |
| BasicEPS | -0.85 | -0.89 | -0.49 | -0.10 |
| DilutedNIAvailtoComStockholders | -7.04M | -5.36M | -2.80M | -585.84K |
| NetIncomeCommonStockholders | -7.04M | -5.36M | -2.80M | -585.84K |
| PreferredStockDividends | 44.98K | |||
| NetIncome | -6.99M | -5.36M | -2.80M | -585.84K |
| NetIncomeIncludingNoncontrollingInterests | -6.99M | -5.36M | -2.80M | -585.84K |
| NetIncomeContinuousOperations | -6.99M | -5.36M | -2.80M | -585.84K |
| PretaxIncome | -6.99M | -5.36M | -2.80M | -585.84K |
| OtherIncomeExpense | -92.96K | 459.00 | 9.92K | |
| OtherNonOperatingIncomeExpenses | -92.96K | 459.00 | 9.92K | |
| SpecialIncomeCharges | -92.96K | 0.00 | 9.92K | |
| OtherSpecialCharges | 92.96K | -9.92K | ||
| NetNonOperatingInterestIncomeExpense | 242.74K | 104.61K | -346.69K | -40.40K |
| InterestExpenseNonOperating | 18.16K | 79.09K | 347.14K | 40.40K |
| InterestIncomeNonOperating | 260.89K | 183.70K | 459.00 | |
| OperatingIncome | -7.24M | -5.37M | -2.46M | -555.36K |
| OperatingExpense | 7.24M | 5.43M | 2.47M | 555.36K |
| ResearchAndDevelopment | 2.22M | 1.43M | 609.27K | 25.00K |
| SellingGeneralAndAdministration | 5.01M | 3.99M | 1.86M | 530.36K |
| GeneralAndAdministrativeExpense | 5.01M | 3.99M | 1.86M | 530.36K |
| OtherGandA | 5.01M | 3.99M | 1.86M | 327.33K |
| SalariesAndWages | 547.85K | 203.03K | ||
| GrossProfit | 0.00 | 59.80K | 9.20K | 0.00 |
| CostOfRevenue | 0.00 | 5.20K | 800.00 | 0.00 |
| TotalRevenue | 0.00 | 65.00K | 10.00K | 0.00 |
| OperatingRevenue | 0.00 | 65.00K | 10.00K | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 9.11M | 6.09M | 5.67M | 5.34M |
| ShareIssued | 9.11M | 6.09M | 5.67M | 5.34M |
| NetDebt | 1.52M | 576.29K | ||
| TotalDebt | 1.58M | 586.30K | ||
| TangibleBookValue | 4.96M | 2.59M | -3.06M | -1.01M |
| InvestedCapital | 4.96M | 2.59M | -1.48M | -422.80K |
| WorkingCapital | 4.96M | 2.59M | -3.07M | -1.01M |
| NetTangibleAssets | 4.96M | 2.59M | -3.06M | -1.01M |
| CommonStockEquity | 4.96M | 2.59M | -3.06M | -1.01M |
| PreferredStockEquity | 1.00 | 1.00 | 1.00 | |
| TotalCapitalization | 4.96M | 2.59M | -3.06M | -1.01M |
| TotalEquityGrossMinorityInterest | 4.96M | 2.59M | -3.06M | -1.01M |
| StockholdersEquity | 4.96M | 2.59M | -3.06M | -1.01M |
| RetainedEarnings | -16.79M | -9.75M | -4.40M | -1.60M |
| AdditionalPaidInCapital | 21.76M | 12.35M | 1.34M | 587.41K |
| CapitalStock | 92.00 | 62.00 | 41.00 | 46.00 |
| CommonStock | 91.00 | 61.00 | 40.00 | 46.00 |
| PreferredStock | 1.00 | 1.00 | 1.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 588.09K | 184.35K | 3.14M | 1.02M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentLiabilities | 588.09K | 184.35K | 3.14M | 1.02M |
| CurrentDeferredLiabilities | 0.00 | 32.00K | 10.00K | |
| CurrentDeferredRevenue | 0.00 | 32.00K | 10.00K | |
| CurrentDebtAndCapitalLeaseObligation | 1.58M | 586.30K | ||
| CurrentDebt | 1.58M | 586.30K | ||
| OtherCurrentBorrowings | 1.58M | 537.30K | ||
| CurrentNotesPayable | 0.00 | 49.00K | ||
| PayablesAndAccruedExpenses | 588.09K | 184.35K | 1.53M | 422.82K |
| CurrentAccruedExpenses | 152.16K | 80.69K | 982.99K | 354.22K |
| Payables | 435.93K | 103.66K | 543.99K | 68.59K |
| AccountsPayable | 435.93K | 103.66K | 543.99K | 68.59K |
| TotalAssets | 5.55M | 2.78M | 80.37K | 10.01K |
| TotalNonCurrentAssets | 4.25K | 5.97K | 7.70K | 0.00 |
| NetPPE | 4.25K | 5.97K | 7.70K | 0.00 |
| AccumulatedDepreciation | -4.49K | -2.77K | -1.04K | |
| GrossPPE | 8.74K | 8.74K | 8.74K | |
| OtherProperties | 8.74K | 8.74K | 8.74K | |
| CurrentAssets | 5.55M | 2.77M | 72.67K | 10.01K |
| PrepaidAssets | 111.60K | 145.88K | 15.00K | 0.00 |
| CashCashEquivalentsAndShortTermInvestments | 5.44M | 2.62M | 57.67K | 10.01K |
| CashAndCashEquivalents | 5.44M | 2.62M | 57.67K | 10.01K |
| CashFinancial | 57.67K | 10.01K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.61M | -6.00M | -919.63K | -382.40K |
| RepaymentOfDebt | -561.88K | -1.02M | -49.00K | 0.00 |
| IssuanceOfDebt | 561.88K | 797.53K | 1.02M | 387.30K |
| IssuanceOfCapitalStock | 8.32M | 7.29M | 0.00 | |
| CapitalExpenditure | -8.74K | |||
| InterestPaidSupplementalData | 18.16K | 93.92K | 5.76K | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 5.44M | 2.62M | 57.67K | 10.01K |
| BeginningCashPosition | 2.62M | 57.67K | 10.01K | 5.02K |
| ChangesInCash | 2.81M | 2.57M | 47.66K | 5.00K |
| FinancingCashFlow | 8.42M | 8.57M | 967.29K | 387.40K |
| CashFlowFromContinuingFinancingActivities | 8.42M | 8.57M | 967.29K | 387.40K |
| NetOtherFinancingCharges | 100.00 | |||
| ProceedsFromStockOptionExercised | 105.82K | 1.49M | 0.00 | |
| NetCommonStockIssuance | 8.32M | 7.29M | 0.00 | |
| CommonStockIssuance | 8.32M | 7.29M | 0.00 | |
| NetIssuancePaymentsOfDebt | 0.00 | -219.95K | 967.29K | 387.30K |
| NetShortTermDebtIssuance | 0.00 | 0.00 | 967.29K | 387.30K |
| ShortTermDebtPayments | -561.88K | -697.53K | -49.00K | 0.00 |
| ShortTermDebtIssuance | 561.88K | 697.53K | 1.02M | 387.30K |
| NetLongTermDebtIssuance | 0.00 | -219.95K | 0.00 | |
| LongTermDebtPayments | 0.00 | -319.95K | 0.00 | |
| LongTermDebtIssuance | 0.00 | 100.00K | 0.00 | |
| InvestingCashFlow | 0.00 | 0.00 | -8.74K | 0.00 |
| CashFlowFromContinuingInvestingActivities | 0.00 | 0.00 | -8.74K | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | 0.00 | -8.74K | 0.00 |
| PurchaseOfPPE | 0.00 | 0.00 | -8.74K | 0.00 |
| OperatingCashFlow | -5.61M | -6.00M | -910.89K | -382.40K |
| CashFlowFromContinuingOperatingActivities | -5.61M | -6.00M | -910.89K | -382.40K |
| ChangeInWorkingCapital | 438.02K | -1.44M | 1.14M | 97.20K |
| ChangeInOtherWorkingCapital | -32.00K | 22.00K | 10.00K | |
| ChangeInPayablesAndAccruedExpense | 403.74K | -1.28M | 1.13M | 87.20K |
| ChangeInAccruedExpense | 71.46K | -838.43K | 654.52K | 113.05K |
| ChangeInPayable | 332.28K | -440.34K | 475.40K | -25.85K |
| ChangeInAccountPayable | 332.28K | -440.34K | 475.40K | -25.85K |
| ChangeInPrepaidAssets | 34.28K | -130.88K | -15.00K | 0.00 |
| OtherNonCashItems | 162.96K | 413.48K | 17.20K | |
| StockBasedCompensation | 943.65K | 631.53K | 340.15K | 98.95K |
| DepreciationAmortizationDepletion | 1.72K | 1.73K | 1.04K | 0.00 |
| DepreciationAndAmortization | 1.72K | 1.73K | 1.04K | 0.00 |
| Depreciation | 1.72K | 1.73K | 1.04K | 0.00 |
| OperatingGainsLosses | -9.92K | |||
| NetIncomeFromContinuingOperations | -6.99M | -5.36M | -2.80M | -585.84K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for BFRG
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|